TF

The Fink Family Office

Europe, England, United Kingdom, London

Description

The Fink Family Office operates as a family investment office.

Investor Profile

The Fink Family Office has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Pre Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Therapeutics, Medical.

Stage Focus

  • Seed (67%)
  • Pre Seed (17%)
  • Series Unknown (17%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Chemical Engineering
  • Industrial Automation
  • Robotics
  • Biopharma
  • Pharmaceutical
  • Advanced Materials
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Fink Family Office frequently co-invest with?

DV
Europe, England, United Kingdom, London
Co-Investments: 1
Longevitytech.fund
North America, Florida, United States, Boca Raton
Co-Investments: 2
Elbow Beach Capital
Europe, England, United Kingdom, London
Co-Investments: 3
Wren Capital
Europe, England, United Kingdom, London
Co-Investments: 2
Oxford Technology Management
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 2
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 2
Cur8 Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Britbots
Europe, England, United Kingdom, London
Co-Investments: 1
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Empirical Ventures
Europe, Bristol, City of, United Kingdom, Bristol
Co-Investments: 6

What are some of recent deals done by The Fink Family Office?

EnsiliTech

Bristol, Bristol, City of, United Kingdom

EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.

BiopharmaMedicalPharmaceuticalVeterinary
SeedAug 28, 2025
Amount Raised: $6,082,273
Argonaute RNA

Bristol, Bristol, City of, United Kingdom

Argonaute RNA company research projects build on existing intellectual property.

Biotechnology
Series UnknownJul 17, 2024
Amount Raised: $2,270,086
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedDec 13, 2023
Amount Raised: $5,048,523
EnsiliTech

Bath, Bath and North East Somerset, United Kingdom

EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.

BiopharmaMedicalPharmaceutical
Pre SeedJan 17, 2023
Amount Raised: $1,105,534
QV Bioelectronics

Manchester, Manchester, United Kingdom

Longer, Better Quality Lives for Brain Tumour Patients

Advanced MaterialsBiotechnologyElectronicsHealth CareLife ScienceMedicalMedical DeviceNanotechnologyNeuroscience
SeedJan 10, 2023
Amount Raised: $2,430,600
cheMastery

London, England, United Kingdom

CheMastery is a company that creates laboratory automation technology.

Chemical EngineeringIndustrial AutomationRobotics
SeedNov 13, 2022
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedApr 25, 2022